Cargando…
Frequency of Regulatory T Cells is Not Affected by Transient B Cell Depletion Using Anti-CD20 Antibodies in Rheumatoid Arthritis
OBJECTIVES: Transient B cell depletion with the monoclonal anti-CD20 antibody rituximab has shown favourable clinical responses in patients with rheumatoid arthritis (RA). Recently a characteristic regeneration pattern of B cell subpopulations has been reported. However, little is known about the im...
Autores principales: | Feuchtenberger, Martin, Müller, Sabine, Roll, Petra, Waschbisch, Anne, Schäfer, Arne, Kneitz, Christian, Wiendl, Heinz, Tony, Hans-Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627533/ https://www.ncbi.nlm.nih.gov/pubmed/19156222 http://dx.doi.org/10.2174/1874312900802010081 |
Ejemplares similares
-
Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report
por: Feuchtenberger, Martin, et al.
Publicado: (2009) -
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
por: Rouzière, Anne-Sophie, et al.
Publicado: (2005) -
The effect of B-cell depletion with an anti-CD20 antibody on the immunoglobulin heavy-chain repertoire in a patient with rheumatoid arthritis
por: Rouzière, A-S, et al.
Publicado: (2005) -
Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
por: Stenner, Max-Philipp, et al.
Publicado: (2008) -
Correction: Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
por: Stenner, Max-Philipp, et al.
Publicado: (2010)